Pagani FD - Search Results

1

Generalizability of Trial Data to Real-World Practice: An Analysis of The Society of Thoracic Surgeons Intermacs Database.

Brescia AA, Watt TMF, Pagani FD, Cascino TM, Zhang M, McCullough JS, Shore S, Likosky DS, Aaronson KD, Cantor RS, Deng L, Kirklin JK, Thompson MP. Brescia AA, et al. Among authors: pagani fd. Ann Thorac Surg. 2022 Oct;114(4):1307-1317. doi: 10.1016/j.athoracsur.2021.08.062. Epub 2021 Oct 5. Ann Thorac Surg. 2022. PMID: 34619136

2

Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.

Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, Moscucci M, Deeb GM, Bolling S, Monaghan H, Aaronson KD. Pagani FD, et al. Circulation. 1999 Nov 9;100(19 Suppl):II206-10. doi: 10.1161/01.cir.100.suppl_2.ii-206. Circulation. 1999. PMID: 10567305

3

The impact of new technology on a clinical practice.

Sonnad SS, Bach DS, Bolling SF, Armstrong WF, Pagani FD, Shea MJ, Monaghan HM, Deeb GM. Sonnad SS, et al. Among authors: pagani fd. Semin Thorac Cardiovasc Surg. 1999 Oct;11(4 Suppl 1):79-82. Semin Thorac Cardiovasc Surg. 1999. PMID: 10660171

4

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy.

Pagani FD, Aaronson KD, Dyke DB, Wright S, Swaniker F, Bartlett RH. Pagani FD, et al. Ann Thorac Surg. 2000 Dec;70(6):1977-84; discussion 1984-5. doi: 10.1016/s0003-4975(00)01998-6. Ann Thorac Surg. 2000. PMID: 11156106

5

LVAD therapy improves utilization of donor hearts: implications for prolonged inotropic therapy.

Aaronson K, Eppinger M, Wright S, Pagani FD. Aaronson K, et al. Among authors: pagani fd. J Heart Lung Transplant. 2001 Feb;20(2):241. doi: 10.1016/s1053-2498(00)00544-1. J Heart Lung Transplant. 2001. PMID: 11250471 No abstract available.

6

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.

Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. Pagani FD, et al. Ann Thorac Surg. 2001 Mar;71(3 Suppl):S77-81; discussion S82-5. doi: 10.1016/s0003-4975(00)02620-5. Ann Thorac Surg. 2001. PMID: 11265871

7

Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.

Pagani FD, Dyke DB, Wright S, Cody R, Aaronson KD. Pagani FD, et al. J Heart Lung Transplant. 2001 Jun;20(6):646-53. doi: 10.1016/s1053-2498(01)00232-7. J Heart Lung Transplant. 2001. PMID: 11404170

8

Prophylactic mitral reconstruction for mitral regurgitation.

Smolens IA, Pagani FD, Deeb GM, Prager RL, Sonnad SS, Bolling SF. Smolens IA, et al. Among authors: pagani fd. Ann Thorac Surg. 2001 Oct;72(4):1210-5; discussion 1215-6. doi: 10.1016/s0003-4975(01)02984-8. Ann Thorac Surg. 2001. PMID: 11603438

9

Safety and efficacy of atorvastatin in heart transplant recipients.

Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD. Patel DN, et al. Among authors: pagani fd. J Heart Lung Transplant. 2002 Feb;21(2):204-10. doi: 10.1016/s1053-2498(01)00369-2. J Heart Lung Transplant. 2002. PMID: 11834348

10

Left ventricular assist device therapy improves utilization of donor hearts.

Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Aaronson KD, et al. Among authors: pagani fd. J Am Coll Cardiol. 2002 Apr 17;39(8):1247-54. doi: 10.1016/s0735-1097(02)01751-5. J Am Coll Cardiol. 2002. PMID: 11955839 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

409 results

Search Page